Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for screening
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
What are the effects of colorectal cancer screening interventions among Asian Americans? A meta-analysis. Objective: Great strides have been made to conduct intervention studies aimed at increasing colorectal cancer (CRC) screening rates that are informed by sound theoretical frameworks and conducted using rigorous methodologies; however, efforts are still gaining wave to understand the efficacy of theory-based interventions among Asian American (AA) population. The purpose of this study (...) was to report the results of a meta-analysis conducted on the effects of CRC screening interventions.Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were used to evaluate the CRC screening interventions. Literature search was performed on October 2018, and studies published in English and conducted in the United States were eligible for inclusion if they (1) conducted interventions with aims to increase CRC screening rates among AA and (2) utilized a randomized
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health professionals, and policymakers.An international guideline panel of 28 multidisciplinary members, including patients, developed questions and corresponding (...) of the European Breast Guidelines provides recommendations regarding organized screening programs for women aged 40 to 75 years who are at average risk. The recommendations address digital mammography screening and the addition of hand-held ultrasonography, automated breast ultrasonography, or magnetic resonance imaging compared with mammography alone. The recommendations also discuss the frequency of screening and inform decision making for women at average risk who are recalled for suspicious lesions or who
Preventive Cancer Screening Among Resettled Refugee Women from Muslim-Majority Countries: A Systematic Review. As refugee populations continue to age in the United States, there is a need to prioritize screening for chronic illnesses, including cancer, and to characterize how social and cultural contexts influence beliefs about cancer and screening behaviors. This study examines screening rates and socio-cultural factors influencing screening among resettled refugee women from Muslim-majority (...) countries of origin. A systematic and integrative review approach was used to examine articles published from 1980 to 2019, using PubMed, CINAHL, and PsycINFO. A total of 20 articles met the inclusion criteria. Cancer screening rates among refugee women are lower when compared to US-born counterparts. Social and cultural factors include religious beliefs about cancer, stigma, modesty and gender roles within the family context. The findings of this review, suggest that resettled refugee women
Pregnancy outcomes associated with an abnormal 50-g glucose screen during pregnancy: a systematic review and Meta-analysis. Objective: To assess the association between an abnormal 1-h 50-g glucose challenge test (GCT) followed by a normal 3-h 100-g glucose tolerance test (GTT) on fetal macrosomia and other adverse outcomes.Data sources: MEDLINE, Cochrane, clinicaltrials.gov, and Google Scholar were searched from inception to March 2019.Methods of study selection: Any studies reporting adverse (...) ), preeclampsia (OR 1.48, 95% CI 1.15-1.91, 17 studies, 110,930 patients), hypoglycemia (OR 1.43, CI 1.07-1.91) and shoulder dystocia (OR 1.52, 95% CI 1.09-2.12, 9 studies, 41,229 patients). Neonatal birth weight was significantly higher in the study group. The incidence of NICU admission, low Apgar score, and respiratory morbidity was similar in the two groups. Controlling for body mass index and 1-h glucose screen cut off did not alter these results.Conclusion: Even in the absence of gestational diabetes
Do we know enough about the effect of low-dose computed tomography screening for lung cancer on survival to act? A systematic review, meta-analysis and network meta-analysis of randomised controlled trials. Diagnosis of lung cancer frequently occurs in its later stages. Low-dose computed tomography (LDCT) could detect lung cancer early.Our objective was to estimate the effect of LDCT lung cancer screening on mortality in high-risk populations. A systematic review of randomised controlled trials (...) (RCTs) comparing LDCT screening programmes with usual care (no screening) or other imaging screening programme (such as chest X-ray (CXR)) was conducted. RCTs of CXR screening were additionally included in the network meta-analysis. Bibliographic sources including MEDLINE, Embase, Web of Science and the Cochrane Library were searched to January 2017. All key review steps were done by two persons. Quality assessment used the Cochrane Risk of Bias tool. Meta-analyses were performed.Four RCTs were
Screening and brief advice for alcohol and tobacco use Screening and brief advice for alcohol and tobacco use - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Screening and brief advice for alcohol and tobacco use Guidance on screening and providing brief advice for alcohol
Guidance for antenatal screening and ultrasound in pregnancy in the evolving coronavirus (COVID-19) pandemic 1 Information for healthcare professionals Version 1: Published Monday 23 March 2020 Guidance for antenatal screening and ultrasound in pregnancy in the evolving coronavirus (COVID-19) pandemic2 Authors Matthew Jolly, NHS England & NHS Improvement Myles T aylor, BMFMS Jane Fisher, ARC Nadia Permalloo, PHE Annette McHugh, PHE Christoph Lees, Imperial College/ISUOG Pranav Pandya, UCLH/PHE (...) Eddie Morris, RCOG Jo Mountfield , RCOG Tim Draycott, RCOG Pat O’Brien, RCOG Ranee Thakar, RCOG Sue Ward, RCOG Jennifer Jardine, RCOG Sophie Relph, RCOG Gemma Goodyear, RCOG3 1. Introduction There are 3 antenatal screening programmes: • Sickle cell and thalassaemia (SCT) • Infectious disease in pregnancy screening (IDPS) • Fetal anomaly screening (FASP) Pregnant women with existing type 1 and type 2 diabetes should also be offered eye screening at, or soon after, their first antenatal visit
Molecular and antibody point-of-care tests to support the screening, diagnosis and monitoring of COVID-19 Molecular and antibody point-of-care tests to support the screening, diagnosis and monitoring of COVID-19 - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Molecular and antibody point-of-care tests to support the screening, diagnosis and monitoring of COVID-19 April 7, 2020 Kile Green 1 , Sara (...) and G (IgM and IgG). IgM is the largest immunoglobulin, and is the first to appear after initial exposure to an antigen. IgG is the most common antibody found in the body, which will appear later but will be generated in abundance. These tests can determine whether a patient has previously been infected with coronavirus, as they will stay positive after active infection has gone. Currently, serological testing is not routinely offered as part of the screening or diagnosis of COVID-19
What tests could potentially be used for the screening, diagnosis and monitoring of COVID-19 and what are their advantages and disadvantages? What tests could potentially be used for the screening, diagnosis and monitoring of COVID-19 and what are their advantages and disadvantages? - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website What tests could potentially be used for the screening, diagnosis
Newborn Screening During the COVID-19 Pandemic Guidance on Newborn Screening During COVID-19 Internet Explorer Alert It appears you are using Internet Explorer as your web browser. Please note, Internet Explorer is no longer up-to-date and can cause problems in how this website functions This site functions best using the latest versions of any of the following browsers: Edge, Firefox, Chrome, Opera, or Safari . You can find the latest versions of these browsers at More Guidance on Newborn (...) Screening During COVID-19 / Guidance on Newborn Screening During COVID-19 April 15, 2020 The American Academy of Pediatrics (AAP) strongly supports the continued provision of health care for children during the COVID-19 pandemic unless community circumstances related to the pandemic require necessary adjustments. Newborn and infant care should be provided consistent with the (4th Edition) and the corresponding (Periodicity Schedule) whenever possible. The AAP recommends that pediatricians continue
COVID-19: Temperature Screening for Healthcare Personnel COVID-19: TEMPERATURE SCREENING FOR HEALTHCARE PERSONNEL A Rapid Guidance Summary from the Penn Medicine Center for Evidence-based Practice Last updated April 21, 2020 11:00 am All links rechecked April 20 unless otherwise noted. Key questions answered in this summary • When should hospitals implement temperature screening for healthcare personnel (HCP)? • What temperature threshold should be used for screening? • What should be done when (...) a HCP is found to have an elevated temperature? Summary of major recommendations • Mass temperature screening programs using external infrared (IR) devices alone are ineffective for detecting infected persons. Overall screening effectiveness can be improved by adopting layered measures. • Daily screening for symptoms of COVID-19 including fever is recommended and may be completed either by the HCP or the healthcare facility. • Some hospitals are using temperature screening of HCP reporting for work
Dental imaging of trabecular bone structure for systemic disorder screening: A systematic review. The purpose of this systematic review was to evaluate the potential use of dental imaging assessment of trabecular bone structure in the maxillomandibular complex as an adjuvant screening tool to identify systemic disorders. Five electronic databases and grey literature were searched. Studies were included if they investigated subjects with altered trabecular bone determined by dental radiographs
Screening for the at-risk mental state in educational settings: A systematic review. The at-risk mental state (ARMS) allows clinicians to identify individuals who have an increased risk of developing psychosis. At present, most screening for psychosis-risk is carried out within help-seeking populations; however, screening within educational settings may allow clinicians to identify individuals at-risk earlier and to increase the rate of detection. This review aimed to examine screening (...) for the ARMS in educational settings, with the key questions: what screening tools have been used in educational settings, can screening in educational settings detect individuals with ARMS, what threshold scores in screening tools indicate a positive screen in educational settings, are there comorbid mental health conditions associated with the ARMS in educational settings?Searches were carried out in PsycINFO, MEDLINE, EMBASE, Scopus and Web of Science and reference lists of included articles searched
Multidimensional screening for predicting pain problems in adults: a systematic review of screening tools and validation studies. Screening tools allowing to predict poor pain outcomes are widely used. Often these screening tools contain psychosocial risk factors. This review (1) identifies multidimensional screening tools that include psychosocial risk factors for the development or maintenance of pain, pain-related distress, and pain-related disability across pain problems in adults, (2 (...) ) evaluates the quality of the validation studies using Prediction model Risk Of Bias ASsessment Tool (PROBAST), and (3) synthesizes methodological concerns. We identified 32 articles, across 42 study samples, validating 7 screening tools. All tools were developed in the context of musculoskeletal pain, most often back pain, and aimed to predict the maintenance of pain or pain-related disability, not pain-related distress. Although more recent studies design, conduct, analyze, and report according to best
Cervical Cancer Screening Access, Outcomes, and Prevalence of Dysplasia in Correctional Facilities: A Systematic Review. Background: Incarcerated women often access health care primarily through contact with correctional systems. Cervical cancer screening within the correctional system can address the preventable outcome of cervical dysplasia and cancer in this high-risk population. Materials and Methods: A search of PubMed, EMBASE, CINAHL, and ClinicalTrials.gov was conducted for articles (...) published between January, 1966 and December, 2018. All studies on a population of jailed or incarcerated females and at least one of the following outcomes: cervical cancer or dysplasia, pap smear screening, knowledge about screening, treatment of cervical dysplasia, and compliance with follow-up were analyzed. Results: Forty-two studies met inclusion criteria. All 21 studies with prevalence outcomes described a higher prevalence of cervical dysplasia and cancer in the women involved with corrections
Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis. Esophageal squamous cell carcinomas (ESCCs) are often accompanied by head and neck second primary tumors (HNSPTs). The prognosis of patients with an additional HNSPT is worse compared with patients with only ESCC. Therefore, early detection of HNSPTs may improve the overall outcome of patients with ESCC. The purpose of this study was to investigate the yield (...) of endoscopic screening for HNSPTs in patients with primary ESCC.We conducted a systematic literature search of all available databases. Studies were included if ESCC patients were endoscopically screened for HNSPT. The primary outcome was the pooled prevalence of HNSPTs.Twelve studies, all performed in Japan, were included in this systematic review with a total of 6483 patients. The pooled prevalence of HNSPTs was 6.7% (95% confidence interval: 4.9-8.4). The overall heterogeneity was high across